ATE139442T1 - Neue verwendung von linomide (r) - Google Patents

Neue verwendung von linomide (r)

Info

Publication number
ATE139442T1
ATE139442T1 AT91905238T AT91905238T ATE139442T1 AT E139442 T1 ATE139442 T1 AT E139442T1 AT 91905238 T AT91905238 T AT 91905238T AT 91905238 T AT91905238 T AT 91905238T AT E139442 T1 ATE139442 T1 AT E139442T1
Authority
AT
Austria
Prior art keywords
linomide
new use
treatment
invention concerns
infections
Prior art date
Application number
AT91905238T
Other languages
English (en)
Inventor
Bo Nilsson
Terje Kalland
Original Assignee
Pharmacia Ab Reg Number 556131
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab Reg Number 556131 filed Critical Pharmacia Ab Reg Number 556131
Application granted granted Critical
Publication of ATE139442T1 publication Critical patent/ATE139442T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91905238T 1990-02-22 1991-02-21 Neue verwendung von linomide (r) ATE139442T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000624A SE9000624D0 (sv) 1990-02-22 1990-02-22 New use

Publications (1)

Publication Number Publication Date
ATE139442T1 true ATE139442T1 (de) 1996-07-15

Family

ID=20378638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91905238T ATE139442T1 (de) 1990-02-22 1991-02-21 Neue verwendung von linomide (r)

Country Status (11)

Country Link
EP (1) EP0516725B1 (de)
JP (1) JPH05503532A (de)
AT (1) ATE139442T1 (de)
AU (1) AU641002B2 (de)
CA (1) CA2076650C (de)
DE (1) DE69120396T2 (de)
DK (1) DK0516725T3 (de)
ES (1) ES2089194T3 (de)
GR (1) GR3020798T3 (de)
SE (1) SE9000624D0 (de)
WO (1) WO1991012804A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9201076L (sv) * 1992-04-06 1993-10-07 Shimon Slavin Användningen av gamla läkemedel för behandling av diabetes
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
SE9400809D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of quinoline-3-carboxamide compounds
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
CA2312406A1 (en) * 1997-12-15 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Drugs augmenting nkt cells
DE60315796T2 (de) * 2002-01-17 2008-06-05 Merck & Co., Inc. Hydroxynaphthyridinoncarbonsäureamide, die sich als inhibitoren der hiv-integrase eignen
US7713535B2 (en) 2003-12-08 2010-05-11 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties by small oligonucleotide-based compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation

Also Published As

Publication number Publication date
DK0516725T3 (da) 1996-09-09
CA2076650A1 (en) 1991-08-23
GR3020798T3 (en) 1996-11-30
AU641002B2 (en) 1993-09-09
DE69120396T2 (de) 1997-01-30
AU7446691A (en) 1991-09-18
ES2089194T3 (es) 1996-10-01
EP0516725A1 (de) 1992-12-09
EP0516725B1 (de) 1996-06-19
SE9000624D0 (sv) 1990-02-22
WO1991012804A1 (en) 1991-09-05
CA2076650C (en) 1998-04-28
JPH05503532A (ja) 1993-06-10
DE69120396D1 (de) 1996-07-25

Similar Documents

Publication Publication Date Title
ES2134764T3 (es) Inhibidores de hiv proteasa.
SE8704298D0 (sv) Compounds for use in therapy
TW249226B (de)
ATE269290T1 (de) Benzoylderivate
DK0458699T3 (da) Anvendelse af baclofen til fremstilling af lægemidler til behandling af angina pectoris
DK163287D0 (da) 1,4-diazepiner og farmaceutiske midler med indhold af saadanne forbindelser
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
DE69120396D1 (de) Neue verwendung von linomide (r)
DK0424156T3 (da) Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser
NO891894D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer.
NO910559D0 (no) Fremgangsmaate for fremstilling av polyfosfasener ved substitusjon av polydiklorfosfasen.
FI952420A0 (fi) Glukopyranosidibentsotiofeenit
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DE3874606D1 (de) Behandlung von viraler infektion.
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen
DE69129126D1 (de) Neue pharmazeutische formulierungen von 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol
SE9000288D0 (sv) New use
MX9202948A (es) Uso de atipamezol.
FI934053A (fi) Antibakteriella aemnen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee